Developer docs
API playgroundTry for free, no card

Search company profiles

BigOmics

Full company profile

uuid0000lp3

Namestring
BigOmics
Legal namestring
BigOmics Analytics SA
Websiteurl
bigomics.ch
Company typeenum
Private
Founded yearint
2021
Descriptiontext

BigOmics Analytics SA is a Swiss cloud-software company that operates the Omics Playground, a self-service data analytics platform for the life sciences. The platform enables biologists, bioinformaticians, and R&D managers in biotech, pharmaceutical, and academic settings to perform interactive RNA-Seq and proteomics analyses — including clustering, differential expression, enrichment, biomarker discovery, drug connectivity, and protein network analysis — without writing code. Built primarily on R Shiny and delivered as a cloud web application, the platform ships 18+ analysis modules and 150+ interactive plots, and is differentiated by built-in co-analysis against 6,000+ public GEO datasets, a 50,000+ gene-set/pathway library, and 30,000+ drug expression profiles. A beta Multi-Omics add-on extends the core product into integrated epigenomics, transcriptomics, proteomics, and metabolomics workflows via SNF, MOFA, DIABLO, and MCIA.

The company sells through a hybrid go-to-market combining a product-led self-serve free trial (up to two years at auth.bigomics.ch) with a sales-led enterprise motion (request-a-demo funnel and dedicated Account Executive coverage of mid-market biotech accounts). Revenue is generated primarily through annual SaaS subscriptions executed via Order Forms, supplemented by training/onboarding services; pricing is quote-based rather than publicly listed. As of October 2025 the company reports 60+ biotech and pharma customers and institutes (including Merck, Sanofi, Vertex Pharmaceuticals, AbbVie, Parabilis Medicines, and Harvard Medical School) and a global researcher community of more than 6,000.

BigOmics is privately held and headquartered in Lugano, Switzerland, with co-founders Murat Akhmedov (CEO) and Ivo Kwee (CTO). The company has raised approximately $3.45M in disclosed venture funding across a December 2021 Pre-Series A, a March 2022 Eppendorf top-up, and an October 2025 round led by Diffusion Capital Partners alongside TiVentures and SICTIC business angels. Strategic partnerships with DNAnexus (proteomics/transcriptomics, 2023) and Almaden Genomics (end-to-end workflows, 2024) extend its ecosystem footprint.

Short descriptiontext

BigOmics Analytics operates Omics Playground, a cloud-based, no-code analytics platform for biologists, bioinformaticians, and pharma R&D teams to perform interactive RNA-Seq, proteomics, and multi-omics data analysis, sold via SaaS subscriptions to biotech, pharmaceutical, and academic customers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLugano, Switzerland
HQ citystring
Lugano
HQ countrystring
Switzerland
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
omics data analysis, RNA-Seq analysis, proteomics analytics, multi-omics integration, drug discovery analytics
Industry4 codes
PRIMARYHLAGAJAD
Bioinformatics & Multi-omics Analysis Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAAANAF
Multi-Omics Precision Medicine Platforms (genomics/proteomics/metabolomics)
SECONDARYHLAGANAI
Bioinformatics, Multi-Omics Data Analysis & Interpretation Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
NAICS code1 code
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Bioinformatics Software
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model3 records
1Omics Playground subscription (SaaS)
TypeSubscription Recurring
Description

Customer purchases subscriptions and access to the Services by executing one or more Order Forms. Fees are non-refundable, exclude VAT, payable within 30 days by wire transfer. Order Forms auto-renew for successive Renewal Terms unless either party gives 90 days notice; BigOmics may raise Fees for Renewal Terms with 90 days notice.

bigomics.ch
2Free trial / freemium tier
TypeFreemium
Description

Free trial offered to enable evaluation prior to a paid plan, with a maximum trial duration of two years. BigOmics reserves the right to modify conditions including feature access, dataset limits, storage capacity and trial duration. Cancelled or non-renewed paid accounts may be automatically downgraded to a free trial plan.

bigomics.ch
3Training, onboarding, and support services
TypeProfessional Services
Description

Training, onboarding, and support services provided as specified on Order Forms; customer pays agreed travel expenses in addition to fees.

bigomics.ch
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations
Pricing details2 tiers
1Free trial plan (up to 2 years, evaluation only)
ModelFreemiumBilling cadencePay-as-you-go
Notes

Maximum trial duration of two years; BigOmics reserves the right to modify feature access, dataset limits, storage capacity, and trial duration; free trial accounts may be suspended and data archived after 2 years or after more than 1 year of inactivity.

bigomics.ch
2Paid subscription (quote-based via Order Form)
ModelSubscriptionBilling cadenceAnnual
Notes

Specific price points not publicly disclosed; Fees negotiated per Order Form, non-refundable, exclude VAT; payable within 30 days; late fees at minimum 1.5% per month; auto-renews for successive Renewal Terms; Fees subject to increase for Renewal Terms with 90 days notice.

bigomics.ch
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 2 records shown
1Omics Playground
Description

Cloud-based, self-service omics data analysis platform for interactive visualization and analysis of RNA-Seq, proteomics, and multi-omics data; includes 18+ analysis modules, 150+ interactive plots, co-analysis with 6000+ public datasets, 50,000+ public gene sets and pathways, and drug connectivity databases.

bigomics.ch
+1 more record
Core offering1 text field

BigOmics Analytics provides a cloud-based, self-service omics data analysis platform (Omics Playground) for biologists, bioinformaticians, and pharma/biotech research teams. The platform delivers interactive visualization and analysis of RNA-Seq, proteomics, and multi-omics data via 18+ analysis modules and 150+ interactive plots, with built-in access to 6,000+ public datasets, 50,000+ gene sets and pathways, and 30,000+ drug expression profiles. An add-on Multi-Omics Playground extends the platform with SNF, MOFA, DIABLO, and MCIA integration methods for multi-layer omics analysis, biomarker discovery, and drug repurposing workflows.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 75% increase in collaboration effectiveness
+6 more records
Product overview1 text field

BigOmics Analytics offers a single unified cloud-based platform, Omics Playground, for interactive omics data analysis, with an add-on module (Multi-Omics Playground) for multi-omics integration and two primary analysis workflows (RNA-Seq Data Analysis and Proteomics Data Analysis) layered on top. The core Omics Playground provides 18+ analysis modules and 150+ interactive plots for biologists, bioinformaticians, and managers, with co-analysis against 6,000+ public datasets and 50,000+ gene sets. The Multi-Omics add-on (in beta) extends the platform with SNF, MOFA, DIABLO, and MCIA integration methods to harmonize transcriptomics, proteomics, epigenomics, and metabolomics data. The platform is positioned as a complete self-service analytics solution for biotech, pharma, and academic labs, also packaged as a Drug Discovery Solution for pharmaceutical R&D.

Product and service5 records
1Omics Playground
CategoryBioinformatics Software Platform
Description

Cloud-based, interactive omics data analysis platform that enables biologists and bioinformaticians to explore, visualize, and interpret RNA-Seq and proteomics data without coding. Provides 18+ analysis modules, 150+ interactive plots, co-analysis with 6,000+ public datasets, and 50,000+ gene sets/pathways for biomarker analysis, drug connectivity, enrichment/pathway analysis, WGCNA and PCSF network analysis, and clustering/differential expression tools.

2Multi-Omics Playground
CategoryBioinformatics Software Module
Description

Beta add-on module that extends Omics Playground with multi-omics data integration across epigenomics, transcriptomics, proteomics, and metabolomics. Uses state-of-the-art integration methods including SNF (Similarity Network Fusion), MOFA (Multi-Omics Factor Analysis), DIABLO (supervised integration), and MCIA (Multiple Co-Inertia Analysis) for code-free multi-omics analysis workflows.

3RNA-Seq Data Analysis
CategoryOmics Analysis Workflow
Description

Specialized workflow within Omics Playground for RNA-Seq data analysis, supporting differential expression analysis, gene set enrichment, pathway analysis, and biomarker identification from bulk and single-cell RNA-seq data.

4Proteomics Data Analysis
CategoryOmics Analysis Workflow
Description

Specialized workflow within Omics Playground for proteomics data analysis, including abundance table ingestion, missing value imputation (e.g., SVDimpute), normalization (e.g., maxMedian), differential protein expression, PSEA, pathway analysis (WikiPathways, Reactome), biomarker identification, drug connectivity, WGCNA and PCSF network analysis. Supports Olink Target proteomics data formats.

5Omics Playground for Drug Discovery
CategoryVertical Solution for Pharma R&D
Description

Solution-oriented offering of Omics Playground configured as a drug discovery solution for pharmaceutical R&D, leveraging biomarker analysis, drug connectivity databases with 30,000+ drug expression profiles, drug sensitivity databases, drug modes of action analysis, and repurposable drug identification.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2024-02-22
Description

Announced February 22, 2024: BigOmics and Almaden Genomics collaborated to provide end-to-end omics data analysis. Partnership spans co-authored case studies (e.g., IL-17A / osteoarthritis RNA-Seq use case) combining Almaden's reagent/sample prep with BigOmics' analysis platform.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2023-08-02
Description

Announced August 2, 2023: DNAnexus and BigOmics Analytics partnered to improve proteomics and transcriptomics data visualization and interpretation. The integration delivers a complete collaborative environment with an intuitive interface addressing common analysis bottlenecks across the two platforms.

3Swiss Biotech Association
Strategic tierMinorTypeOthers
Description

BigOmics is a member of the Swiss Biotech Association (swissbiotech.org); member logo displayed in homepage footer.

bigomics.ch
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Cloud-based genomics and biomedical data analysis platform serving pharma, clinical, and academic customers. Direct peer — DNAnexus is both BigOmics' Aug 2023 integration partner and a broader cloud-bioinformatics competitor offering overlapping omics analysis and visualization.

TypeDirect peer
Description

Enterprise bioinformatics platform for pharma R&D, including omics data analysis, screening, and biopharma workflow automation. Direct peer serving the same biotech/pharma buyer with code-free analytical workflows similar in spirit to Omics Playground.

TypeBroad incumbent
Description

Broad incumbent in omics data analysis and interpretation, including OmicSoft and Ingenuity Pathway Analysis, serving pharma, academic, and clinical customers. Larger, more established alternative to BigOmics with deeper pharma footprint and a much broader product portfolio.

TypeDirect peer
Description

Genomics and multi-omics analysis software (Partek Flow, Partek Genomics Suite) used by biologists and bioinformaticians for RNA-Seq, single-cell, and multi-omics workflows. Direct peer in code-assisted omics analytics targeting overlapping academic and pharma buyer personas.

TypeBroad incumbent
Description

Scientific R&D informatics platform spanning biology, chemistry, and lab data, including omics and biomarker workflows. Broad incumbent offering overlapping omics analytics capabilities as part of a much wider scientific data platform aimed at enterprise pharma.

TypeDirect peer
Description

Cloud bioinformatics platform for NGS, multi-omics, and biomedical data analysis serving pharma, research consortia, and clinical customers. Direct peer offering code-free and programmatic omics workflows over large public reference datasets similar to BigOmics' co-analysis library.

TypeEmerging player
Description

Cloud-based omics analytics platform targeting biologists in pharma and biotech with no-code analysis of RNA-Seq, proteomics, and other omics data. Emerging player with a similar no-code, biologist-friendly thesis and a smaller, more focused product surface than BigOmics.

TypeEmerging player
Description

Cloud-based, code-free omics analysis platform originally targeted at academic and translational researchers, now part of Tempus AI. Emerging peer with a similar PLG, code-free analytical approach and overlapping biological user persona.

TypeBroad incumbent
Description

Sequencing-instrument incumbent that also offers cloud bioinformatics (BaseSpace, Illumina Connected Analytics) for secondary and tertiary omics analysis. Broad incumbent with significant reach into BigOmics' academic and pharma customer base via installed sequencer footprints.

TypeOthers
Description

Proteomics platform using Proximity Extension Assay technology, which BigOmics' Omics Playground directly supports as an analysis workflow (Aug 2025 tutorial). Adjacent ecosystem participant — BigOmics ingests and analyses Olink data, making Olink a strategic ecosystem partner rather than a direct competitor.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers19 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration5 records

Each record includes

Title, Type, Description, Source

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature10 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors9 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BigOmics

Bioinformatics Softwarebigomics.ch

BigOmics Analytics operates Omics Playground, a cloud-based, no-code analytics platform for biologists, bioinformaticians, and pharma R&D teams to perform interactive RNA-Seq, proteomics, and multi-omics data analysis, sold via SaaS subscriptions to biotech, pharmaceutical, and academic customers.

What BigOmics does

BigOmics Analytics SA is a Swiss cloud-software company that operates the Omics Playground, a self-service data analytics platform for the life sciences. The platform enables biologists, bioinformaticians, and R&D managers in biotech, pharmaceutical, and academic settings to perform interactive RNA-Seq and proteomics analyses — including clustering, differential expression, enrichment, biomarker discovery, drug connectivity, and protein network analysis — without writing code. Built primarily on R Shiny and delivered as a cloud web application, the platform ships 18+ analysis modules and 150+ interactive plots, and is differentiated by built-in co-analysis against 6,000+ public GEO datasets, a 50,000+ gene-set/pathway library, and 30,000+ drug expression profiles. A beta Multi-Omics add-on extends the core product into integrated epigenomics, transcriptomics, proteomics, and metabolomics workflows via SNF, MOFA, DIABLO, and MCIA.

The company sells through a hybrid go-to-market combining a product-led self-serve free trial (up to two years at auth.bigomics.ch) with a sales-led enterprise motion (request-a-demo funnel and dedicated Account Executive coverage of mid-market biotech accounts). Revenue is generated primarily through annual SaaS subscriptions executed via Order Forms, supplemented by training/onboarding services; pricing is quote-based rather than publicly listed. As of October 2025 the company reports 60+ biotech and pharma customers and institutes (including Merck, Sanofi, Vertex Pharmaceuticals, AbbVie, Parabilis Medicines, and Harvard Medical School) and a global researcher community of more than 6,000.

BigOmics is privately held and headquartered in Lugano, Switzerland, with co-founders Murat Akhmedov (CEO) and Ivo Kwee (CTO). The company has raised approximately $3.45M in disclosed venture funding across a December 2021 Pre-Series A, a March 2022 Eppendorf top-up, and an October 2025 round led by Diffusion Capital Partners alongside TiVentures and SICTIC business angels. Strategic partnerships with DNAnexus (proteomics/transcriptomics, 2023) and Almaden Genomics (end-to-end workflows, 2024) extend its ecosystem footprint.

BigOmics firmographics

Firmographics
Name
BigOmics
Legal name
BigOmics Analytics SA
Website
https://bigomics.ch
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
11–50 employees
Short description
BigOmics Analytics operates Omics Playground, a cloud-based, no-code analytics platform for biologists, bioinformaticians, and pharma R&D teams to perform interactive RNA-Seq, proteomics, and multi-omics data analysis, sold via SaaS subscriptions to biotech, pharmaceutical, and academic customers.
Ownership category
akta.pro rank

BigOmics industry classification

Industry
Product category
Bioinformatics Software
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAJAD
Bioinformatics & Multi-omics Analysis Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAAANAF
Multi-Omics Precision Medicine Platforms (genomics/proteomics/metabolomics)
SECONDARYHLAGANAI
Bioinformatics, Multi-Omics Data Analysis & Interpretation Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

Keywords

  • Omics data analysis
  • RNA-Seq analysis
  • Proteomics analytics
  • Multi-omics integration
  • Drug discovery analytics

Where BigOmics is headquartered

Location

Headquarters

HQ city
Lugano
HQ country
Switzerland
HQ region
Europe

Offices2 records

Markets served

BigOmics business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations

Revenue model

  1. Omics Playground subscription (SaaS): Customer purchases subscriptions and access to the Services by executing one or more Order Forms. Fees are non-refundable, exclude VAT, payable within 30 days by wire transfer. Order Forms auto-renew for successive Renewal Terms unless either party gives 90 days notice; BigOmics may raise Fees for Renewal Terms with 90 days notice.
  2. Free trial / freemium tier: Free trial offered to enable evaluation prior to a paid plan, with a maximum trial duration of two years. BigOmics reserves the right to modify conditions including feature access, dataset limits, storage capacity and trial duration. Cancelled or non-renewed paid accounts may be automatically downgraded to a free trial plan.
  3. Training, onboarding, and support services: Training, onboarding, and support services provided as specified on Order Forms; customer pays agreed travel expenses in addition to fees.

Pricing tiers

ModelBillingPrice
FreemiumPay-as-you-goFree trial plan (up to 2 years, evaluation only)
SubscriptionAnnualPaid subscription (quote-based via Order Form)

Go-to-market motion4 records

Distribution channels3 records

Marketing channels8 records

BigOmics product offering

Product offering

Core offering

BigOmics Analytics provides a cloud-based, self-service omics data analysis platform (Omics Playground) for biologists, bioinformaticians, and pharma/biotech research teams. The platform delivers interactive visualization and analysis of RNA-Seq, proteomics, and multi-omics data via 18+ analysis modules and 150+ interactive plots, with built-in access to 6,000+ public datasets, 50,000+ gene sets and pathways, and 30,000+ drug expression profiles. An add-on Multi-Omics Playground extends the platform with SNF, MOFA, DIABLO, and MCIA integration methods for multi-layer omics analysis, biomarker discovery, and drug repurposing workflows.

Product overview

BigOmics Analytics offers a single unified cloud-based platform, Omics Playground, for interactive omics data analysis, with an add-on module (Multi-Omics Playground) for multi-omics integration and two primary analysis workflows (RNA-Seq Data Analysis and Proteomics Data Analysis) layered on top. The core Omics Playground provides 18+ analysis modules and 150+ interactive plots for biologists, bioinformaticians, and managers, with co-analysis against 6,000+ public datasets and 50,000+ gene sets. The Multi-Omics add-on (in beta) extends the platform with SNF, MOFA, DIABLO, and MCIA integration methods to harmonize transcriptomics, proteomics, epigenomics, and metabolomics data. The platform is positioned as a complete self-service analytics solution for biotech, pharma, and academic labs, also packaged as a Drug Discovery Solution for pharmaceutical R&D.

Differentiator

Problem solved

Functional benefit

Brands

  • Omics Playground: Cloud-based, self-service omics data analysis platform for interactive visualization and analysis of RNA-Seq, proteomics, and multi-omics data; includes 18+ analysis modules, 150+ interactive plots, co-analysis with 6000+ public datasets, 50,000+ public gene sets and pathways, and drug connectivity databases.
  • Multi-Omics Playground

Products and services

  • Omics Playground Cloud-based, interactive omics data analysis platform that enables biologists and bioinformaticians to explore, visualize, and interpret RNA-Seq and proteomics data without coding. Provides 18+ analysis modules, 150+ interactive plots, co-analysis with 6,000+ public datasets, and 50,000+ gene sets/pathways for biomarker analysis, drug connectivity, enrichment/pathway analysis, WGCNA and PCSF network analysis, and clustering/differential expression tools.
  • Multi-Omics Playground Beta add-on module that extends Omics Playground with multi-omics data integration across epigenomics, transcriptomics, proteomics, and metabolomics. Uses state-of-the-art integration methods including SNF (Similarity Network Fusion), MOFA (Multi-Omics Factor Analysis), DIABLO (supervised integration), and MCIA (Multiple Co-Inertia Analysis) for code-free multi-omics analysis workflows.
  • RNA-Seq Data Analysis Specialized workflow within Omics Playground for RNA-Seq data analysis, supporting differential expression analysis, gene set enrichment, pathway analysis, and biomarker identification from bulk and single-cell RNA-seq data.
  • Proteomics Data Analysis Specialized workflow within Omics Playground for proteomics data analysis, including abundance table ingestion, missing value imputation (e.g., SVDimpute), normalization (e.g., maxMedian), differential protein expression, PSEA, pathway analysis (WikiPathways, Reactome), biomarker identification, drug connectivity, WGCNA and PCSF network analysis. Supports Olink Target proteomics data formats.
  • Omics Playground for Drug Discovery Solution-oriented offering of Omics Playground configured as a drug discovery solution for pharmaceutical R&D, leveraging biomarker analysis, drug connectivity databases with 30,000+ drug expression profiles, drug sensitivity databases, drug modes of action analysis, and repurposable drug identification.

Quantifiable outcome

  • 75% increase in collaboration effectiveness
  • +6 more outcomes

Companies that use BigOmics

Customer profile

Named customers19 records

Segments5 records

Ideal customer profiles4 records

BigOmics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability7 records

Feature10 records

BigOmics partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered major, core and minor.

  • Almaden GenomicsmajorStrategic or Co-development Partner · 22 February 2024Announced February 22, 2024: BigOmics and Almaden Genomics collaborated to provide end-to-end omics data analysis. Partnership spans co-authored case studies (e.g., IL-17A / osteoarthritis RNA-Seq use case) combining Almaden's reagent/sample prep with BigOmics' analysis platform.
  • DNAnexuscoreTechnology or Integration · 2 August 2023Announced August 2, 2023: DNAnexus and BigOmics Analytics partnered to improve proteomics and transcriptomics data visualization and interpretation. The integration delivers a complete collaborative environment with an intuitive interface addressing common analysis bottlenecks across the two platforms.
  • Swiss Biotech AssociationminorOthersBigOmics is a member of the Swiss Biotech Association (swissbiotech.org); member logo displayed in homepage footer.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

BigOmics competitors and assessment

Company assessment

Direct peers

  • DNAnexus: Cloud-based genomics and biomedical data analysis platform serving pharma, clinical, and academic customers. Direct peer — DNAnexus is both BigOmics' Aug 2023 integration partner and a broader cloud-bioinformatics competitor offering overlapping omics analysis and visualization.
  • Genedata: Enterprise bioinformatics platform for pharma R&D, including omics data analysis, screening, and biopharma workflow automation. Direct peer serving the same biotech/pharma buyer with code-free analytical workflows similar in spirit to Omics Playground.
  • Partek: Genomics and multi-omics analysis software (Partek Flow, Partek Genomics Suite) used by biologists and bioinformaticians for RNA-Seq, single-cell, and multi-omics workflows. Direct peer in code-assisted omics analytics targeting overlapping academic and pharma buyer personas.
  • Seven Bridges (Velsera): Cloud bioinformatics platform for NGS, multi-omics, and biomedical data analysis serving pharma, research consortia, and clinical customers. Direct peer offering code-free and programmatic omics workflows over large public reference datasets similar to BigOmics' co-analysis library.

Broad incumbents

  • QIAGEN Digital Insights (QIAGEN Bioinformatics / OmicSoft): Broad incumbent in omics data analysis and interpretation, including OmicSoft and Ingenuity Pathway Analysis, serving pharma, academic, and clinical customers. Larger, more established alternative to BigOmics with deeper pharma footprint and a much broader product portfolio.
  • Dotmatics: Scientific R&D informatics platform spanning biology, chemistry, and lab data, including omics and biomarker workflows. Broad incumbent offering overlapping omics analytics capabilities as part of a much wider scientific data platform aimed at enterprise pharma.
  • Illumina (Illumina Connected Analytics / BaseSpace): Sequencing-instrument incumbent that also offers cloud bioinformatics (BaseSpace, Illumina Connected Analytics) for secondary and tertiary omics analysis. Broad incumbent with significant reach into BigOmics' academic and pharma customer base via installed sequencer footprints.

Emerging players

  • Pluto Bio: Cloud-based omics analytics platform targeting biologists in pharma and biotech with no-code analysis of RNA-Seq, proteomics, and other omics data. Emerging player with a similar no-code, biologist-friendly thesis and a smaller, more focused product surface than BigOmics.
  • Rosalind (Tempus): Cloud-based, code-free omics analysis platform originally targeted at academic and translational researchers, now part of Tempus AI. Emerging peer with a similar PLG, code-free analytical approach and overlapping biological user persona.

Others

  • Olink (now part of Thermo Fisher Scientific): Proteomics platform using Proximity Extension Assay technology, which BigOmics' Omics Playground directly supports as an analysis workflow (Aug 2025 tutorial). Adjacent ecosystem participant — BigOmics ingests and analyses Olink data, making Olink a strategic ecosystem partner rather than a direct competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

BigOmics social profiles

Digital presence

BigOmics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BigOmics leadership team

Management profile

Number of profiles

Profiles3 records

BigOmics funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors9 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BigOmics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BigOmics

What does BigOmics do?

BigOmics Analytics provides a cloud-based, self-service omics data analysis platform (Omics Playground) for biologists, bioinformaticians, and pharma/biotech research teams. The platform delivers interactive visualization and analysis of RNA-Seq, proteomics, and multi-omics data via 18+ analysis modules and 150+ interactive plots, with built-in access to 6,000+ public datasets, 50,000+ gene sets and pathways, and 30,000+ drug expression profiles. An add-on Multi-Omics Playground extends the platform with SNF, MOFA, DIABLO, and MCIA integration methods for multi-layer omics analysis, biomarker discovery, and drug repurposing workflows.

Is BigOmics a public or private company?

BigOmics is a private company. It is classified as venture growth investor backed and is currently operating.

When was BigOmics founded?

BigOmics was founded in 2021. It employs 11 to 50 people.

Where is BigOmics based?

BigOmics is headquartered in Lugano, Switzerland, in the Europe region.

How does BigOmics make money?

Three revenue lines are on record. Omics Playground subscription (SaaS) is the primary driver. The others are free trial / freemium tier and training, onboarding, and support services.

Who are BigOmics's main competitors?

Direct peers on record are DNAnexus, Genedata, Partek and Seven Bridges (Velsera). Broad incumbents are QIAGEN Digital Insights (QIAGEN Bioinformatics / OmicSoft), Dotmatics and Illumina (Illumina Connected Analytics / BaseSpace). Emerging players are Pluto Bio and Rosalind (Tempus). Olink (now part of Thermo Fisher Scientific) is listed as an others.

Does BigOmics have an API?

No public API is recorded for BigOmics.

What industry is BigOmics in?

BigOmics's product category is Bioinformatics Software. Its primary akta.pro industry code is HLAGAJAD, Bioinformatics & Multi-omics Analysis Software, with a secondary code of HLAAANAF, Multi-Omics Precision Medicine Platforms (genomics/proteomics/metabolomics). Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
StartupSeekerBigOmics AnalyticsBigOmics Analytics offers the Omics Playground, an interactive platform designed to streamline RNA-Seq and proteomics data analysis for biologists and bioinformaticians. The solution provides over 18 analysis modules and 150 visualizations to reduce workflow inefficiencies and enhance collaboration. The company is based in Munich, Germany, and was founded in 2018.startupticker.chBigOmics Analytics raises USD 1.6 million to advance precision medicineSwiss bioinformatics company BigOmics Analytics raised $1.6 million in the first tranche of a funding round to expand product development and scale infrastructure for enterprise and clinical applications. The capital, backed by investors including Diffusion Capital Partners and TiVentures, will support the growth of its Omics Playground platform used by over 60 biotech and pharma companies.BigomicsBigOmics Analytics Raises the First Tranche of its Next RoundSwiss bioinformatics company BigOmics Analytics has successfully closed the first tranche of its next funding round, raising $1.6 million from new investors Diffusion Capital Partners and SICTIC business angels, alongside continued support from existing investor TiVentures. The capital will be used to accelerate product development of its Omics Playground platform, enhance AI-powered capabilities, expand into new markets, and scale infrastructure for enterprise and clinical applications. The company reports a global community of over 6,000 researchers and more than 60 biotech and pharma companies using its platform for data analysis in cancer research, neurodegenerative diseases, and immunology.startupticker.chBigOmics attracts leading lab equipment manufacturer as investorEppendorf, a leading life science company, has invested in BigOmics Analytics, a Swiss startup focused on biodata analytics, raising their total funding to CHF 2.7 million. Eppendorf aims to enhance laboratory work processes and integrate BigOmics' data analysis capabilities with their existing digital solutions for researchers. The investment reflects a strategic move to improve R&D efficiency and support data-driven therapeutics and precision medicine.BigomicsBigOmics Raises $1.85M to Revolutionize Omics Data AnalyticsBigOmics Analytics SA raised $1.85 million in financing to expand its team and commercialize its governed self-service analytics platforms for life scientists. This funding round was led by TiVentures and included several other investors, coming on top of $430,000 raised earlier this year. The company aims to disrupt omics data analysis processes and accelerate scientific discovery in data-driven therapeutics and precision medicine.startupticker.chDemocratising Biodata Analytics with BigOmicsBigOmics, a Ticino-based biotech startup, signed a partnership with BC Platforms and was selected for EU and US accelerators. Its VirOmics Playground, launched in early 2020 for Covid-19 research, was visited by over 5,000 users in Q2. The company aims to democratize biological data analysis for life science research.